Catalyst Wire Dossier Catalyst Wire Dossier

ViraferonPeg

Pegylated interferon alfa-2b · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ViraferonPeg, covering 2010-06-07 to 2021-01-22. Get the full timeline:

Most recent: EMA Withdrawn: ViraferonPeg (peginterferon alfa-2b) — Merck Sharp Dohme Ltd

See pricing